Drug Type Small molecule drug |
Synonyms hyperphosphatemia therapy (Ardelyx), NaP2b inhibitors (Sanofi), RDX-002 |
Target |
Mechanism NaPi-2b inhibitors(Sodium-dependent phosphate transport protein 2B inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hyperphosphatemia | Preclinical | US | 01 Sep 2015 | |
Hyperphosphatemia | Preclinical | FR | 01 Sep 2015 |